Business Coach
9562
D. Western Therapeutics Institute
4576
Daiwa Cycle
5888
Artra Group
6029
Liberta
4935
(Q1)Aug 31, 2024 | (FY)May 31, 2024 | (Q4)May 31, 2024 | (Q3)Feb 29, 2024 | (Q2)Nov 30, 2023 | (Q1)Aug 31, 2023 | (FY)May 31, 2023 | (Q4)May 31, 2023 | (Q3)Feb 28, 2023 | (Q2)Nov 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 9.52%20.99B | 14.77%88.68B | 27.99%28.96B | 13.24%18.84B | 7.16%21.71B | 8.05%19.16B | 5.77%77.26B | -2.32%22.63B | -3.13%16.64B | 24.04%20.26B |
Cost of revenue | -3.66%7.07B | 16.68%34.7B | 38.59%12.38B | 9.61%6.34B | 3.91%8.63B | 9.42%7.34B | 2.09%29.74B | -15.08%8.94B | -8.62%5.79B | 23.94%8.31B |
Gross profit | 17.72%13.91B | 13.58%53.97B | 21.07%16.58B | 15.19%12.5B | 9.43%13.08B | 7.20%11.82B | 8.21%47.52B | 8.30%13.69B | 0.06%10.85B | 24.12%11.95B |
Operating expense | 17.94%11.18B | 18.79%43.48B | 28.53%14.12B | 19.06%9.75B | 14.14%10.12B | 10.82%9.48B | 11.82%36.6B | 6.40%10.99B | 6.79%8.19B | 22.19%8.87B |
Operating profit | 16.82%2.73B | -3.87%10.5B | -9.24%2.46B | 3.27%2.75B | -4.12%2.96B | -5.35%2.34B | -2.35%10.92B | 16.75%2.71B | -16.18%2.66B | 30.03%3.08B |
Net non-operating interest income (expenses) | -32.24%103M | 18.23%629M | -53.13%75M | 44.87%226M | 49.15%176M | 55.10%152M | 257.05%532M | 81.82%160M | 225.00%156M | 1,080.00%118M |
Non-operating interest income | 2.37%173M | 38.75%845M | 12.83%211M | 17.90%191M | 85.14%274M | 50.89%169M | 139.76%609M | 48.41%187M | 128.17%162M | 362.50%148M |
Non-operating interest expense | 311.76%70M | 180.52%216M | 403.70%136M | -683.33%-35M | 226.67%98M | 21.43%17M | -26.67%77M | -28.95%27M | -73.91%6M | 36.36%30M |
Net investment income | -159.73%-270M | -35.77%544M | -40.71%268M | -8.09%-187M | 126.19%11M | -25.90%452M | 41.17%847M | 52.19%452M | -1,630.00%-173M | -112.77%-42M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | -786.27%-350M | -668.18%-125M | 0 | 215.91%51M | 320.00%22M | 146.77%29M | ||||
Income from associates and other participating interests | -143.48%-56M | -32.94%-678M | 87.07%-57M | -100.00%-38M | -1,547.06%-560M | -43.75%-23M | -598.63%-510M | -2,494.12%-441M | -19M | -34M |
Special income (charges) | -26,500.00%-266M | 14,365.00%11.57B | 12,763.33%11.58B | 0.00%-2M | 33.33%-2M | 80.00%-1M | -98.23%80M | -97.96%90M | -100.78%-2M | -3M |
Less:Other special charges | --263M | -11,640.40%-11.62B | ---- | ---- | ---- | ---- | 98.01%-99M | ---- | ---- | ---- |
Less:Write off | 200.00%3M | 168.42%51M | 411.11%46M | 0.00%2M | -33.33%2M | -80.00%1M | -95.67%19M | -97.91%9M | 100.00%2M | --3M |
Other non-operating income (expenses) | -61.76%52M | -38.31%351M | -93.93%21M | 13,400.00%133M | -63.25%61M | 134.48%136M | 121.40%569M | 3,560.00%346M | -100.84%-1M | 361.11%166M |
Income before tax | -24.96%2.29B | 80.69%22.56B | 326.56%14.21B | 8.43%2.88B | -26.49%2.42B | -4.92%3.05B | -24.78%12.49B | -52.88%3.33B | -23.50%2.66B | 24.55%3.29B |
Income tax | 6.86%1.15B | 117.16%6.33B | 853.14%3.34B | 98.51%802M | 3.84%1.11B | -1.10%1.08B | -31.81%2.91B | -77.51%350M | -51.50%404M | 55.60%1.07B |
Net income | -42.38%1.14B | 69.58%16.24B | 264.76%10.88B | -7.73%2.08B | -41.14%1.31B | -6.88%1.98B | -22.33%9.57B | -45.92%2.98B | -14.70%2.25B | 13.62%2.22B |
Net income continuous operations | -42.33%1.14B | 69.59%16.24B | 264.76%10.88B | -7.73%2.08B | -41.10%1.31B | -6.88%1.98B | -22.34%9.57B | -45.93%2.98B | -14.66%2.25B | 13.62%2.22B |
Noncontrolling interests | -26.67%11M | -11.90%74M | 46.67%22M | -137.50%-3M | 2.56%40M | -31.82%15M | 18.31%84M | -21.05%15M | 0.00%8M | 25.81%39M |
Net income attributable to the company | -42.47%1.13B | 70.32%16.16B | 265.89%10.86B | -7.31%2.08B | -41.88%1.27B | -6.63%1.96B | -22.58%9.49B | -46.02%2.97B | -14.71%2.24B | 13.42%2.18B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -42.47%1.13B | 70.32%16.16B | 265.89%10.86B | -7.31%2.08B | -41.88%1.27B | -6.63%1.96B | -22.58%9.49B | -46.02%2.97B | -14.71%2.24B | 13.42%2.18B |
Gross dividend payment | ||||||||||
Basic earnings per share | -41.82%25.71 | 70.68%365.22 | 266.95%245.56 | -7.27%46.91 | -41.89%28.56 | -6.61%44.19 | -22.48%213.98 | -45.96%66.92 | -14.69%50.59 | 13.38%49.15 |
Diluted earnings per share | -41.82%25.71 | 70.68%365.22 | 267.06%245.56 | -7.27%46.91 | -41.95%28.5335 | -6.61%44.19 | -22.48%213.98 | -45.97%66.9 | -14.65%50.59 | 13.50%49.15 |
Dividend per share | 0 | 18.18%65 | 14.29%40 | 0 | 25.00%25 | 0 | 22.22%55 | 29.63%35 | 0 | 11.11%20 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |